![Paul Burgess](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Burgess
Företagsledare/Principal på
CEREVEL THERAPEUTICS HOLDINGS, INC.
Förmögenhet: - $ per 2026-05-31
Profil
Paul Burgess is Chief Business Development Officer at Cerevel Therapeutics Holdings, Inc. since 2023 and Chief Operating & Business Officer at Kailera Therapeutics, Inc. since 2024.
Former roles include Director-Intellectual Property at Logical Therapeutics, Inc., In-House Counsel at Johnson & Johnson, Vice President-Intellectual Property at DNIB Unwind, Inc. from 2008 to 2015, Secretary, Chief Operating & Legal Officer at Translate Bio, Inc. from 2019 to 2021, Head-Intellectual Property at Civitas Therapeutics, Inc. from 2011 to 2015, Vice President-Intellectual Property at Scholar Rock, Inc. from 2015 to 2016, and Head-Legal at TransForm Pharmaceuticals, Inc. Education includes an undergraduate degree from Merrimack College in 1995 and graduate degrees from Northeastern University in 1999 and 2002.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
-.--% | 2026-04-17 | 0 ( -.--% ) | - $ | 2026-05-31 |
Aktiva positioner av Paul Burgess
| Företag | Position | Start |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Företagsledare/Principal | 2023-06-20 |
Tidigare kända positioner av Paul Burgess
| Företag | Position | Slut |
|---|---|---|
| TRANSLATE BIO, INC. | Verksamhetschef | 2021-09-14 |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Företagsledare/Principal | 2016-04-01 |
| DNIB UNWIND INC | Företagsledare/Principal | 2015-07-01 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Företagsledare/Principal | 2015-02-01 |
TransForm Pharmaceuticals, Inc.
 TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Generell Rådgivare | - |
Paul Burgesss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
87
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
DNIB Unwind, Inc.
 DNIB Unwind, Inc. BiotechnologyHealth Technology Develops biopharmaceutical preparations | Health Technology |
Translate Bio, Inc.
 Translate Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage mRNA therapeutics company that develops transformative medicines to treat diseases caused by protein | Health Technology |
Merrimack College
 Merrimack College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
Logical Therapeutics, Inc.
 Logical Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops products that treat diseases associated with inflammation | Health Technology |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative pulmonary delivery therapies | Health Technology |
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Operates as a biotechnology company | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
